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Abstract
Aim This comment addresses conflicts of interest in the
publication of research results.
Subject and Methods Based on the concept of values in
science, the problem of scientific misconduct related to
publishing research results is treated hermeneutically. Franz
Porzsolt’s approach to assessing studies and the implica-
tions for solving conflicts of interest are evaluated.
Results It is argued that conflicts of interest reflect the
difficulty of balancing values in science and that science
would become arbitrary and worthless for sponsors of
research if it lacked its traditional values.
Conclusion Keeping scientific values and coping with
conflicts of interest are essential for the future credibility
and accountability of scientific endeavors. The communi-
tarian approach to Twin Assessment of Clinical Studies
might answer both demands.
Keywords Values . Publication ethics . Conflict of interest
“Scientists behaving badly” was the title of a study on
scientific misconduct published in Nature in 2005. More
than 3,200 researchers answered the question whether they
had had to report any personal scientific misconduct or
unethical behavior regarding their work during the last
3 years. The result was astonishing since a great majority
rather openly admitted to having betrayed, deceived or
engaged in another behavior considered as inappropriate in
research. Furthermore, the study showed both a general
awareness of the fact that certain ethical norms exist in
research and an awareness that these norms are not always
followed. Listed among the top ten behaviors were “not
properly disclosing involvement in firms whose products are
based on one’s own research,” “failing to present data that
contradict one’s own previous research”, and “changing the
design, methodology or result of a study in response to
pressure from a funding source” (Martinson et al. 2005). The
sample of these misconducts reflects the difficult position of
scientists between institutional academic values and personal
interests that might either be internally motivated (for
example, by ambition) or externally fostered (for example,
by sponsors).
Robert Merton once determined a group of central
institutional ethical norms that constituted a basic value
set in science. These norms included an organized
skepticism, disinterestedness—including academic freedom
unbiased by authorities, universalism and finally the open
communication of research results labeled as "communism"
(Merton (1942) 1973). In face of the dictum that ‘science
goes where the money is,’ these values seem to be
anachronistic, and it might be asked whether alternative
norms do not capture the reality of science much better.
Would it not be clever for a scientist to promote the norms of
capitalism, particularism and interestedness as key elements
during the daily struggle for reputation, funding and research
grants? Indeed, a recent (pilot)study by Macfarlane and
Cheng suggests that especially disinterestedness as a scien-
tific norm loses support. Aligning research with funding
opportunities has become common—with female researchers
more likely to act in such a pragmatic way than male
(Macfarlane and Cheng 2008). In addition, previous studies
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have shown that this stance also results in a publication
bias: sponsorship of research by industries was statistically
significantly correlated with pro-industry conclusions
(Bekelman et al. 2003).
However—and this is the crucial point—industry can only
benefit from pro-industry conclusions made by scientists if
consumers, stakeholders, other scientists, and finally industri-
al representatives themselves believe in the scientific values of
universalism, communism, disinterestedness and scepticism.
Otherwise, pro-industry conclusions were arbitrary and
worthless or “valueless,” respectively. Values are the capital
of science. Thus, scientists and their sponsors work and act
within a stress field of values. This stress field is a font of
conflicts of interest, the most prominent of which relate to the
role of the scientist as a disinterested searcher for universal
scientific facts and his dependence on sponsors. The sponsors
might be inclined to have facts dressed, tuned and selected,
because their economic profit is closely connected to scientific
opinion framing. In order to back traditional values in science,
many medical journals have implemented conflict of interest
disclosure policies with limited success. It has to be kept in
mind that not only researchers, but also journal editors and
owners have an interest in cooperation with sponsors (Lexchin
and Light 2006).
Franz Porzsolt’s study on “Advantages and Limitations
of Twin Assessment of Clinical Trials” addresses exactly
this stress field resulting from competing values. He offers
a tool to foster peer assessment on a collaborative
communitarian level that intends to overcome individual
conflicts of interest. Nevertheless, his study and his
experience in conducting the study show how difficult it
is for the individual scientists to balance the good means of
peer assessment with maybe an end (outcome) that is
against one’s own interests. In his study Porzsolt mentions
an industry-based and a university-based referee who
assessed the analyzed papers initially. The industry-based
referee, however, abstained from being listed among the
authors of the study, because the outcome of the assessment
contradicted his genuine interest to work in favor of his
employer (Porzsolt, personal communication). This is not
only a legitimate but also a wise behavior, and the fact that
Porzsolt’s study is now published despite one referee’s
retreat shows that the communitarian approach of twin
assessment is a useful attempt at fostering traditional values
in science. Keeping scientific values and coping with
conflicts of interest are essential for the future credibility
and accountability of scientific endeavors. Thus, the aware-
ness of a conflict of interest and coping with it without being
relativistic are generally a good sign. It shows that scientific
values prevail and that they prevent science from becoming
arbitrary or being reduced to absurdity.
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